Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study

Authors

• José Gomes Batista Federal University of Paraíba; Obstetrics and Gynecology Department
• José Maria Soares-Jr Universidade de São Paulo; Faculdade de Medicina; Hospital das Clínicas
• Carla Cristina Maganhin Federal University of São Paulo; Gynecology Department
• Ricardo Santos Simões Universidade de São Paulo; Faculdade de Medicina; Hospital das Clínicas
• Geraldez Tomaz Federal University of Paraíba; Obstetrics and Gynecology Department
• Edmund Chada Baracat Universidade de São Paulo; Faculdade de Medicina; Hospital das Clínicas